Invention Grant
- Patent Title: Kits and methods for detecting cancer-related mutations
-
Application No.: US16959557Application Date: 2019-01-06
-
Publication No.: US11952632B2Publication Date: 2024-04-09
- Inventor: Danny Frumkin , Adam Wasserstrom , Revital Knirsh
- Applicant: NUCLEIX LTD.
- Applicant Address: IL Rehovot
- Assignee: NUCLEIX LTD.
- Current Assignee: NUCLEIX LTD.
- Current Assignee Address: IL Rehovot
- Agency: Acuity Law Group, PC
- Agent Michael A. Whittaker
- International Application: PCT/IL2019/050027 2019.01.06
- International Announcement: WO2019/135241A 2019.07.11
- Date entered country: 2020-07-01
- Main IPC: C12P19/34
- IPC: C12P19/34 ; C12N5/09 ; C12N15/10 ; C12N15/66 ; C12Q1/6827 ; C12Q1/6886 ; G01N33/574

Abstract:
Methods and kits for detection of cancer-related mutations in a DNA sample using enzymatic restriction and real-time PCR. A DNA sample is subjected to digestion with a restriction endonuclease to obtain restriction endonuclease-treated DNA, followed by co-amplification of a restriction locus comprising a cancer mutation site and a control locus. A ratio of signal intensities of the amplification products of the restriction locus and the control locus is used to detect the cancer-related mutation.
Information query